Literature DB >> 2653922

Cholinergic treatments for Alzheimer's disease.

F Roberts1, S Lazareno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2653922     DOI： 10.1042/bst0170076

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  3 in total

1.  Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach.

Authors:  W Kromer; E Baron; M Beinborn; R Boer; M Eltze
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

Review 2.  Alzheimer's disease: fundamental and therapeutic aspects.

Authors:  M Schorderet
Journal:  Experientia       Date:  1995-02-15

3.  GRK5 Deficiency Leads to Selective Basal Forebrain Cholinergic Neuronal Vulnerability.

Authors:  Minchao He; Prabhakar Singh; Shaowu Cheng; Qiang Zhang; Wei Peng; XueFeng Ding; Longxuan Li; Jun Liu; Richard T Premont; Dave Morgan; Jeffery M Burns; Russell H Swerdlow; William Z Suo
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.